Advertisement
Advertisement

ANVS

ANVS logo

Annovis Bio, Inc.

1.79
USD
Sponsored
+0.01
+0.56%
Jun 16, 15:56 UTC -4
Closed
exchange

After-Market

1.79

0.00
0.00%

ANVS Earnings Reports

Positive Surprise Ratio

ANVS beat 10 of 22 last estimates.

45%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.46
Implied change from Q1 26 (Revenue/ EPS)
--
/
-26.98%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+43.75%

Annovis Bio, Inc. earnings per share and revenue

On May 15, 2026, ANVS reported earnings of -0.63 USD per share (EPS) for Q1 26, missing the estimate of -0.40 USD, resulting in a -56.37% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.29% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.46 USD, with revenue projected to reach -- USD, implying an decrease of -26.98% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Annovis Bio, Inc. reported EPS of -$0.63, missing estimates by -56.37%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.29%, changed from $2.13 before the earnings release to $2.06 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 5 analysts, Annovis Bio, Inc. is expected to report EPS of -$0.46 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement